WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
BDRX
BIODEXA PHARMACEUTICALS PLC
$6.73M$1.32$8.00506.06%Strong Buy1N/AN/AN/AN/A
XLO
XILIO THERAPEUTICS INC
$37.23M$1.08N/AN/AN/AN/AN/AN/AN/AN/A
SNGX
SOLIGENIX INC
$4.17M$0.40N/AN/AN/AN/A7.18%N/AN/AN/A
AIM
AIM IMMUNOTECH INC
$19.46M$0.39N/AN/AN/AN/AN/AN/AN/AN/A
FRES
FRESH2 GROUP LTD
$4.40M$0.49N/AN/AN/AN/AN/AN/AN/AN/A
CKPT
CHECKPOINT THERAPEUTICS INC
$49.96M$1.40$19.001,257.14%Strong Buy21,423.38%N/AN/AN/A
TOVX
THERIVA BIOLOGICS INC
$6.96M$0.41N/AN/AN/AN/AN/AN/AN/AN/A
CERE
CEREVEL THERAPEUTICS HOLDINGS INC
$7.74B$42.63$44.133.51%Hold8N/AN/AN/AN/A
PROK
PROKIDNEY CORP
$495.38M$2.16$2.5015.74%Hold2N/AN/AN/AN/A
ADVM
ADVERUM BIOTECHNOLOGIES INC
$203.19M$9.79$28.00186.01%Strong Buy4N/AN/AN/AN/A
REVB
REVELATION BIOSCIENCES INC
$3.51M$2.15N/AN/AN/AN/AN/AN/AN/AN/A
INBX
INHIBRX INC
$1.63B$34.30$27.00-21.28%Buy1N/AN/AN/AN/A
SONN
SONNET BIOTHERAPEUTICS HOLDINGS INC
$5.71M$1.86$18.50894.62%Strong Buy2N/AN/AN/AN/A
CGEN
COMPUGEN LTD
$175.95M$1.99$4.50126.13%Strong Buy2-2.46%N/AN/AN/A
PTCT
PTC THERAPEUTICS INC
$2.62B$34.16$33.60-1.64%Buy5-3.92%N/AN/AN/A
GYRE
GYRE THERAPEUTICS INC
$1.18B$13.86N/AN/AN/AN/A-23.95%N/AN/AN/A
TRVN
TREVENA INC
$7.04M$0.38$9.002,243.75%Buy1143.13%N/AN/AN/A
CYTK
CYTOKINETICS INC
$6.53B$63.37$87.3637.86%Strong Buy11296.96%N/AN/AN/A
CHRS
COHERUS BIOSCIENCES INC
$232.19M$2.06$9.33353.06%Strong Buy328.83%N/AN/AN/A
MCRB
SERES THERAPEUTICS INC
$163.09M$1.08$4.75339.81%Hold35.95%N/AN/AN/A
CELU
CELULARITY INC
$58.52M$3.02N/AN/AN/AN/A73.55%N/AN/AN/A
INAB
IN8BIO INC
$45.02M$1.04$8.83749.33%Strong Buy3N/AN/AN/AN/A
ASMB
ASSEMBLY BIOSCIENCES INC
$72.76M$13.27N/AN/AN/AN/AN/AN/AN/AN/A
ESLA
ESTRELLA IMMUNOPHARMA INC
$38.44M$1.05N/AN/AN/AN/AN/AN/AN/AN/A
BIOR
BIORA THERAPEUTICS INC
$19.46M$0.64$50.007,688.16%Buy11,023.11%N/AN/AN/A
CARA
CARA THERAPEUTICS INC
$41.48M$0.76$4.63509.35%Buy4-24.56%N/AN/AN/A
PRTG
PORTAGE BIOTECH INC
$4.55M$0.23$6.002,508.70%Buy1N/AN/AN/AN/A
NVCT
NUVECTIS PHARMA INC
$118.16M$6.65N/AN/AN/AN/AN/AN/AN/AN/A
AVBP
ARRIVENT BIOPHARMA INC
$510.18M$16.69$29.2575.25%Strong Buy4N/AN/AN/AN/A
VANI
VIVANI MEDICAL INC
$91.26M$1.66N/AN/AN/AN/AN/AN/AN/AN/A
NAMS
NEWAMSTERDAM PHARMA CO NV
$1.96B$21.97$33.2551.34%Strong Buy45.19%N/AN/AN/A
NBY
NOVABAY PHARMACEUTICALS INC
$2.71M$0.09N/AN/AN/AN/AN/AN/AN/AN/A
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS INC
$6.48M$2.88N/AN/AN/AN/AN/AN/AN/AN/A
BOLD
BOUNDLESS BIO INC
N/A$10.00$23.00130.00%Strong Buy3N/AN/AN/AN/A
NBSE
NEUBASE THERAPEUTICS INC
$1.55M$0.42N/AN/AN/AN/AN/AN/A-955.09%-468.62%
ANL
ADLAI NORTYE LTD
$520.88M$14.13N/AN/AN/AN/AN/AN/AN/AN/A
MNPR
MONOPAR THERAPEUTICS
$11.35M$0.65$2.00207.69%Strong Buy1N/AN/AN/AN/A
SCPX
SCORPIUS HOLDINGS INC
$6.63M$0.18N/AN/AN/AN/A136.49%N/AN/AN/A
NEXI
NEXIMMUNE INC
$4.36M$3.18N/AN/AN/AN/AN/AN/AN/AN/A
VSTM
VERASTEM INC
$252.45M$9.98$27.63176.80%Strong Buy4N/AN/AN/AN/A
BCDA
BIOCARDIA INC
$10.05M$0.38$4.00963.83%Buy1116.89%N/AN/AN/A
QNRX
QUOIN PHARMACEUTICALS LTD
$2.62M$0.71$4.00463.38%Strong Buy1N/AN/AN/AN/A
APLM
APOLLOMICS INC
$37.50M$0.42$5.751,272.32%Strong Buy2N/AN/AN/AN/A
KALV
KALVISTA PHARMACEUTICALS INC
$513.85M$12.18$29.50142.20%Buy2N/AN/AN/AN/A
VERU
VERU INC
$218.11M$1.49$3.33123.69%Buy3-18.63%N/AN/AN/A
SAVA
CASSAVA SCIENCES INC
$957.01M$22.14$124.00460.07%Buy1N/AN/AN/AN/A
COEP
COEPTIS THERAPEUTICS HOLDINGS INC
$12.27M$0.34N/AN/AN/AN/AN/AN/AN/AN/A
MNMD
MIND MEDICINE (MINDMED) INC
$389.78M$9.43$38.25305.62%Strong Buy4N/AN/AN/AN/A
PHIO
PHIO PHARMACEUTICALS CORP
$3.49M$0.76$4.00425.62%Buy1N/AN/AN/AN/A
LCTX
LINEAGE CELL THERAPEUTICS INC
$213.04M$1.13$6.50475.22%Strong Buy2N/AN/AN/AN/A
IMUX
IMMUNIC INC
$116.91M$1.30$10.00669.23%Strong Buy1N/AN/AN/AN/A
TIL
INSTIL BIO INC
$69.72M$10.72$27.67158.09%Buy3N/AN/AN/AN/A
PXMD
PAXMEDICA INC
$5.10M$0.69$3.00336.05%Buy1N/AN/AN/AN/A
CDXS
CODEXIS INC
$218.64M$3.11$9.50205.47%Strong Buy26.00%N/AN/AN/A
ANRO
ALTO NEUROSCIENCE INC
$432.83M$16.10$32.33100.83%Strong Buy3N/AN/AN/AN/A
INDP
INDAPTUS THERAPEUTICS INC
$17.30M$2.03$12.00492.30%Buy1N/AN/AN/AN/A
ELEV
ELEVATION ONCOLOGY INC
$194.60M$4.00$7.0075.00%Buy3N/AN/AN/AN/A
XRTX
XORTX THERAPEUTICS INC
$5.12M$2.56$14.00446.45%Strong Buy1N/AN/AN/AN/A
IMNN
IMUNON INC
$12.31M$1.31$13.00892.37%Buy1N/AN/AN/AN/A
OGEN
ORAGENICS INC
$4.57M$1.02N/AN/AN/AN/AN/AN/AN/AN/A
FBLG
FIBROBIOLOGICS INC
$258.79M$7.93N/AN/AN/AN/AN/AN/AN/AN/A
CALC
CALCIMEDICA INC
$64.01M$5.96$19.00218.79%Strong Buy4N/AN/AN/AN/A
KOD
KODIAK SCIENCES INC
$185.36M$3.53$3.33-5.58%Strong Sell3N/AN/AN/AN/A
CNTX
CONTEXT THERAPEUTICS INC
$21.71M$1.36$4.00194.12%Buy1N/AN/AN/AN/A
XTLB
XTL BIOPHARMACEUTICALS LTD
$14.17M$2.60N/AN/AN/AN/AN/AN/AN/AN/A
CYBN
CYBIN INC
$143.93M$0.35$5.001,328.57%Buy1N/AN/AN/AN/A
KYTX
KYVERNA THERAPEUTICS INC
$716.14M$16.61$39.50137.81%Strong Buy2N/AN/AN/AN/A
VERA
VERA THERAPEUTICS INC
$2.30B$42.32$32.29-23.71%Strong Buy7N/AN/AN/AN/A
KZIA
KAZIA THERAPEUTICS LTD
$7.88M$0.30N/AN/AN/AN/AN/AN/AN/AN/A
TSVT
2SEVENTY BIO INC
$236.03M$4.60$11.67153.63%Buy3-2.56%N/AN/AN/A
ADXN
ADDEX THERAPEUTICS LTD
$8.12M$8.11N/AN/AN/AN/AN/AN/AN/AN/A
ALRN
AILERON THERAPEUTICS INC
$70.61M$4.16$19.00356.73%Strong Buy1N/AN/A-1,675.81%-108.87%
AGEN
AGENUS INC
$277.74M$13.26$130.00880.39%Strong Buy222.58%N/AN/AN/A
AKBA
AKEBIA THERAPEUTICS INC
$259.62M$1.24$5.00303.23%Strong Buy23.45%N/AN/AN/A
MDGL
MADRIGAL PHARMACEUTICALS INC
$4.19B$210.59$352.1867.24%Buy11N/AN/AN/AN/A
AVTX
AVALO THERAPEUTICS INC
$16.55M$16.00$35.00118.75%Buy1-20.50%N/AN/AN/A
VAXX
VAXXINITY INC
$14.58M$0.12N/AN/AN/AN/AN/AN/AN/AN/A
SMMT
SUMMIT THERAPEUTICS INC
$3.30B$4.70$8.0070.21%Strong Buy1N/AN/AN/AN/A
EVAX
EVAXION BIOTECH A
$14.82M$3.91$11.00181.33%Strong Buy2817.27%N/AN/AN/A
DARE
DARE BIOSCIENCE INC
$33.19M$0.33$6.001,718.18%Buy1242.88%N/AN/AN/A
BBIO
BRIDGEBIO PHARMA INC
$4.75B$27.03$49.6783.75%Strong Buy6275.99%N/AN/AN/A
OMER
OMEROS CORP
$197.01M$3.40N/AN/AN/AN/AN/AN/A-180.90%11.95%
FGEN
FIBROGEN INC
$115.56M$1.17N/AN/AN/AN/A13.61%N/AN/AN/A
GUTS
FRACTYL HEALTH INC
$320.78M$6.70$18.00168.66%Strong Buy11,336.08%N/AN/AN/A
CSBR
CHAMPIONS ONCOLOGY INC
$66.07M$4.86N/AN/AN/AN/A27.17%N/AN/AN/A
CERO
CERO THERAPEUTICS HOLDINGS INC
$20.32M$1.38N/AN/AN/AN/AN/AN/AN/AN/A
LBPH
LONGBOARD PHARMACEUTICALS INC
$790.94M$21.96$43.3397.33%Strong Buy6N/AN/AN/AN/A
BIVI
BIOVIE INC
$19.66M$0.49$5.00914.20%Buy1N/AN/AN/AN/A
BPTH
BIO-PATH HOLDINGS INC
$1.87M$2.76$40.001,349.28%Strong Buy2N/AN/AN/AN/A
RGLS
REGULUS THERAPEUTICS INC
$164.32M$2.51$7.25188.84%Buy4N/AN/AN/AN/A
CADL
CANDEL THERAPEUTICS INC
$234.19M$7.98$11.0037.84%Buy1N/AN/AN/AN/A
PHGE
BIOMX INC
$24.57M$0.45$2.00349.44%Buy1N/AN/AN/AN/A
MLEC
MOOLEC SCIENCE SA
$50.34M$1.34$6.00347.76%Strong Buy1102.36%N/AN/AN/A
RENB
RENOVARO INC
$211.19M$1.47N/AN/AN/AN/AN/AN/AN/AN/A
MYMD
MYMD PHARMACEUTICALS INC
$6.90M$3.20N/AN/AN/AN/AN/AN/AN/AN/A
NCNA
NUCANA PLC
$8.42M$3.98$100.002,412.56%Buy1N/AN/AN/AN/A
CTCX
CARMELL CORP
$39.45M$2.05N/AN/AN/AN/AN/AN/AN/AN/A
MBIO
MUSTANG BIO INC
$2.70M$0.26N/AN/AN/AN/AN/AN/AN/AN/A
GRI
GRI BIO INC
$1.36M$0.42N/AN/AN/AN/AN/AN/AN/AN/A
ANEB
ANEBULO PHARMACEUTICALS INC
$76.76M$2.96N/AN/AN/AN/AN/AN/AN/AN/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 4.87% over the past year, overperforming other biotech stocks by 26 percentage points.

Corcept Therapeutics has an average 1 year price target of $39.33, an upside of 64.71% from Corcept Therapeutics's current stock price of $23.88.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.73% over the past year, underperforming other biotech stocks by -9 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 41.52% from Incyte's current stock price of $52.94.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -93.23% over the past year, underperforming other biotech stocks by -72 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 469.95% from Amylyx Pharmaceuticals's current stock price of $1.93.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.06%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.44%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and up 3.18% over the last week. Cytomx Therapeutics was the among the top gainers in the biotechnology industry, gaining 214.72% yesterday.

CytomX Therapeutics shares are trading higher after the company announced that it will report Q1 2024 results and provide an initial CX-904 Phase 1a dose escalation update on May 8, 2024.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -29.73% in the past year. It has underperformed other stocks in the biotech industry by -9 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.55% in the past year. It has performed in line with other stocks in the biotech industry.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Amylyx Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Amylyx Pharmaceuticals's stock has dropped -93.23% in the past year. It has underperformed other stocks in the biotech industry by -72 percentage points.

Are biotech stocks a good buy now?

49.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 84.82% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 7.71x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.